 |
CASE STUDIES : |
|
|
|
|
|
Office Central de la Pharmacie
|
 |
|
Diadeis Mission
OCP (Office Central de la Pharmacie) is France's biggest pharmaceutical dispatcher with 40.5% of the market. It has 8 regional platforms and 59 dispatch centres. It distributes 24,500 standard products, making 4 million products in all. <dernière phrase effacée>
DIADEIS has developed the editorial system and document database for use on a variety of media (CLICKADOC system)
The main DIADEIS mission is the monthly updating, design, duplication, and routing of CD-ROMs. DIADEIS also carries out the page layout for "Dico Plus" (OCP's yearly printed reference catalogue) using automated composition. DIADEIS is also involved in the evolution of the CD-ROM features.
|
|
Process
Monthly CD-ROM production process:
Receipt of new data for updating the CLICKADOC CD-ROM
Verification of data integrity
Processing of data for incorporation into CD-ROM
Production and validation of Worm
Duplication of CD-ROMS
Routing of CD-ROMS
|
|
Technology
ORACLE V8i database / Intermedia
Production of generic APIs for developing web interfaces for the application
XML entry of product data sheets
XML extraction of product data sheets for the CD-ROM
Production of the CD-ROM using DIADEIS technology
CDBL
DICOPLUS book composed with CCI and QuarkXpress
|
|
Human resources
One project leader
Two development engineers
One data entry operator (CD-ROM)
A DTP team
|
|
Volume
11,000 CD-ROMs produced each month
300,000 product data sheets (medication and nonprescribed products)
Composition of 1,900 pages for DICOPLUS
|
|
Main challenge
Enable real time updating of the customer's Web site and shorten the delivery time of CD-ROMS to the OCP customers' dispensaries.
|
|
Input
XML product data sheets.
|
|
|
Output
Monthly production of product data search CD-ROM and yearly production of the printed DICOPLUS publication.
|
|
|
Result
OCP has the biggest pharmaceutical products database in Europe that can be accessed by extranet (5, 500 dispensary subscribers), with the added feature of managing foreign equivalents (equivalent products) and managing drug contraindications.
|
|
|
|
